Atlas Trials

Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan

Clinical trial NCT01514240 · COMPLETED

Trial details

NCT number
NCT01514240
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2012-02-01
Primary completion
2014-09-01
Enrollment
123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.